SENJU PHARMACEUTICAL CO., LTD.;KYOTO PREFECTURAL PUBLIC UNIVERSITY CORPORATION;THE DOSHISHA
发明人:
Noriko KOIZUMI,Naoki OKUMURA,Shigeru KINOSHITA
申请号：
US15523231
公开号：
US20170319693A1
申请日:
2015.10.30
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention provides a technique for treating the cornea. More specifically, the present invention is an agent for the treatment or prevention of a state of corneal endothelial disease, the agent including at least one factor selected from the group consisting of laminin and fragments thereof, wherein the problem is solved by also providing a technique characterized in that this agent is administered together with corneal endothelial cells. Specifically, the present invention can include laminin 511 (α5β1γ1), laminin 521 (α5β2γ1), or a fragment of these.
